Relation of Bariatric Surgery to Inpatient Cardiovascular Outcomes (from the National Inpatient Sample)

Tran Nguyen1, Talal Alzahrani1, Ari Mandler1

  • 1Division of Cardiology, Department of Medicine, The George Washington University, Washington, DC.

Insights

Bariatric surgery (BS) significantly reduces the risk of major adverse cardiovascular events (MACE) in obese hospitalized patients. This finding highlights BS as a protective strategy against cardiovascular complications in individuals with obesity.

Area of Science:

  • Cardiology
  • Bariatric Surgery
  • Public Health

Background:

  • Obesity is a significant public health issue in the US, affecting approximately one in three patients.
  • Obesity is strongly linked to increased cardiovascular disease (CVD) mortality.
  • Bariatric surgery (BS) is an effective method for excess weight reduction.

Purpose of the Study:

  • To investigate the association between bariatric surgery (BS) and major adverse cardiovascular events (MACE) in obese hospitalized patients.
  • To analyze the impact of BS on cardiovascular outcomes among a large cohort of US inpatients.

Main Methods:

  • Retrospective analysis of 1,700,943 obese adult patients (BMI ≥35 kg/m²) from the National Inpatient Sample (2012-2016).
  • Comparison of clinical characteristics and MACE rates between patients with and without a history of BS.
  • Multivariate analysis adjusted for cardiovascular disease risk factors.

Main Results:

  • Out of 1,700,943 obese patients, 50,296 (2.96%) had a history of BS.
  • Obese patients with a history of BS showed a 1.6-fold decreased odds of MACE (OR 0.62; 95% CI, 0.60-0.65; p <0.001).
  • This association remained significant after adjusting for CVD risk factors.

Conclusions:

  • A history of bariatric surgery is associated with significantly lower odds of inpatient MACE in obese patients (BMI ≥35 kg/m²).
  • BS may serve as a protective factor against major adverse cardiovascular events in the context of severe obesity.
  • Further research can explore the long-term cardiovascular benefits of BS in obese populations.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
131
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
111
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
138